A Berkeley School of Public Health research team has been awarded a $3.6 million, five-year grant by the National Institutes of Health to develop new approaches for simulating and optimizing surveillance networks that detect infectious diseases.
An initiative launched two years ago by UC Berkeley and UC San Francisco to use CRISPR-Cas9 gene editing to develop new disease therapies is expanding into research on the planet’s major crops and poorly understood microbiomes.
Doctors have had great success using vaccines to boost the immune system to fight infectious diseases like smallpox and measles, but only recently have immune system boosters been tried against cancer.
UC Berkeley is known as No. 1 for producing serial entrepreneurs, and that fearless ethos doesn’t drive only our students. It also drives our faculty, says Amy Herr, the new faculty director of the Bakar Fellows Program.